Counterfactual Phenotyping with Censored Time-to-Events

02/22/2022
by   Chirag Nagpal, et al.
2

Estimation of treatment efficacy of real-world clinical interventions involves working with continuous outcomes such as time-to-death, re-hospitalization, or a composite event that may be subject to censoring. Causal reasoning in such scenarios requires decoupling the effects of confounding physiological characteristics that affect baseline survival rates from the effects of the interventions being assessed. In this paper, we present a latent variable approach to model heterogeneous treatment effects by proposing that an individual can belong to one of latent clusters with distinct response characteristics. We show that this latent structure can mediate the base survival rates and helps determine the effects of an intervention. We demonstrate the ability of our approach to discover actionable phenotypes of individuals based on their treatment response on multiple large randomized clinical trials originally conducted to assess appropriate treatments to reduce cardiovascular risk.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
08/19/2019

gfoRmula: An R package for estimating effects of general time-varying treatment interventions via the parametric g-formula

Researchers are often interested in using longitudinal data to estimate ...
research
03/06/2021

Identifying Principal Stratum Causal Effects Conditional on a Post-treatment Intermediate Response

In neoadjuvant trials on early-stage breast cancer, patients are usually...
research
02/24/2023

Recovering Sparse and Interpretable Subgroups with Heterogeneous Treatment Effects with Censored Time-to-Event Outcomes

Studies involving both randomized experiments as well as observational d...
research
04/06/2017

Treatment-Response Models for Counterfactual Reasoning with Continuous-time, Continuous-valued Interventions

Treatment effects can be estimated from observational data as the differ...
research
02/15/2023

Multimodal N-of-1 trials: A Novel Personalized Healthcare Design

N-of-1 trials aim to estimate treatment effects on the individual level ...

Please sign up or login with your details

Forgot password? Click here to reset